709
Views
5
CrossRef citations to date
0
Altmetric
Review

Targeting the TGF-β signaling pathway for fibrosis therapy: a patent review (2015–2020)

ORCID Icon, , , , &
Pages 723-743 | Received 22 Oct 2020, Accepted 24 Feb 2021, Published online: 17 May 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Mengying Yao, Dawei Lian, Meizhu Wu, Yuting Zhou, Yi Fang, Siyu Zhang, Wenqiang Zhang, Yanyan Yang, Renfeng Li, Hong Chen, Youqin Chen, Aling Shen & Jun Peng. (2023) Isoliensinine Attenuates Renal Fibrosis and Inhibits TGF-β1/Smad2/3 Signaling Pathway in Spontaneously Hypertensive Rats. Drug Design, Development and Therapy 17, pages 2749-2762.
Read now
Zhihao Gu, Yong Yan, Hequan Yao, Kejiang Lin & Xuanyi Li. (2022) Targeting the LPA1 signaling pathway for fibrosis therapy: a patent review (2010-present). Expert Opinion on Therapeutic Patents 32:10, pages 1097-1122.
Read now

Articles from other publishers (3)

Min Tang, Cheng Guo, Mengxue Sun, Hao Zhou, Xin Peng, Jianli Dai, Qin Ding, Ying Wang & Changqing Yang. (2022) Effective delivery of osteopontin small interference RNA using exosomes suppresses liver fibrosis via TGF-β1 signaling. Frontiers in Pharmacology 13.
Crossref
Jian-Li Qiu, Guo-Feng Zhang, Yu-Na Chai, Xiao-Yan Han, Hai-Tao Zheng, Xiang-Feng Li, Fei Duan & Ling-Yan Chen. (2022) Ligustrazine Attenuates Liver Fibrosis by Targeting miR-145 Mediated Transforming Growth Factor- β /Smad Signaling in an Animal Model of Biliary Atresia . Journal of Pharmacology and Experimental Therapeutics 381:3, pages 257-265.
Crossref
Vincent Yeung, Sriniwas Sriram, Jennifer A. Tran, Xiaoqing Guo, Audrey E. K. Hutcheon, James D. Zieske, Dimitrios Karamichos & Joseph B. Ciolino. (2021) FAK Inhibition Attenuates Corneal Fibroblast Differentiation In Vitro. Biomolecules 11:11, pages 1682.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.